Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

TFFP

Tff Pharmaceuticals Inc

Oct 04 • 04:00PM ET

1.87

Dollar change 0.00
Percentage change 0.00	%

Healthcare • Biotechnology • USA • NASD

Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-7.96	Insider Own	10.44%	Shs Outstand	3.47M	Perf Week	-6.50%
Market Cap	6.49M	Forward P/E	-	EPS next Y	-3.77	Insider Trans	0.00%	Shs Float	3.10M	Perf Month	-4.59%
Income	-19.39M	PEG	-	EPS next Q	-0.81	Inst Own	18.70%	Short Float	4.81%	Perf Quarter	-4.10%
Sales	0.00M	P/S	-	EPS this Y	63.88%	Inst Trans	-	Short Ratio	3.89	Perf Half Y	-58.35%
Book/sh	1.81	P/B	1.03	EPS next Y	11.92%	ROA	-168.10%	Short Interest	0.15M	Perf Year	-78.00%
Cash/sh	1.27	P/C	1.48	EPS next 5Y	-	ROE	-213.51%	52W Range	1.35 - 11.00	Perf YTD	-73.36%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-13.86%	ROI	-329.84%	52W High	-83.00%	Beta	1.36
Dividend TTM	-	Quick Ratio	1.63	Sales past 5Y	0.00%	Gross Margin	-	52W Low	38.52%	ATR (14)	0.24
Dividend Ex-Date	-	Current Ratio	1.63	EPS Y/Y TTM	61.32%	Oper. Margin	0.00%	RSI (14)	44.11	Volatility	12.14% 11.31%
Employees	19	Debt/Eq	0.01	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	30.00
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	64.78%	Payout	-	Rel Volume	0.18	Prev Close	1.87
Sales Surprise	333.47%	EPS Surprise	28.24%	Sales Q/Q	-	Earnings	Aug 14 AMC	Avg Volume	38.30K	Price	1.87
SMA20	-9.57%	SMA50	-6.17%	SMA200	-50.88%	Trades		Volume	6,932	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
May-19-22	Resumed	H.C. Wainwright	Buy	$22
Feb-08-21	Initiated	H.C. Wainwright	Buy	$31
Dec-07-20	Initiated	B. Riley Securities	Buy	$36
Aug-17-20	Reiterated	Maxim Group	Buy	$12 → $18
Jul-08-20	Initiated	Maxim Group	Buy	$12

Sep-26-24 07:00AM	TFF Pharmaceuticals' Technology Generates Superior Inhalational Dry Powder Formulations for Pulmonary Drug Delivery (GlobeNewswire) +10.77%
Sep-11-24 07:00AM	TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVID (GlobeNewswire) +11.28%
Sep-10-24 07:00AM	TFF Pharmaceuticals Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal Immunization (GlobeNewswire)
Sep-03-24 08:00AM	TFF Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire) -6.97%
Aug-14-24 09:54PM	TFFP Stock Earnings: TFF Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace)
05:20PM	Loading…
05:20PM	TFF Pharmaceuticals, Inc. (TFFP) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	TFF Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-06-24 08:00AM	TFF Pharmaceuticals Provides Continued Positive Outcomes from Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection (GlobeNewswire)
Jun-26-24 07:00AM	TFF Pharmaceuticals Engages Outcome Capital As a Strategic Advisor for Evaluating Partnership and Licensing Opportunities (GlobeNewswire) -12.18%
Jun-24-24 07:00AM	TFF Pharmaceuticals Provides Regulatory Update on Tacrolimus Inhalation Powder (TFF TAC) Clinical Program for the Prevention of Lung Transplant Rejection (GlobeNewswire) +9.20%
Jun-19-24 06:00AM	3 52-Week-Low Losers Ready to Become Big-Time Stock Winners (InvestorPlace)
May-23-24 07:00AM	TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical Testing (GlobeNewswire) -6.42%
May-20-24 11:37AM	TFF Pharmaceuticals Advances Influenza Vaccine Candidates Into Preclinical Testing (MT Newswires) +6.02%
07:00AM	TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing (GlobeNewswire)
May-15-24 07:00AM	TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection (GlobeNewswire) +8.06%
10:54PM	Loading…
May-14-24 10:54PM	TFFP Stock Earnings: TFF Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:00PM	TFF Pharmaceuticals, Inc. (TFFP) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	TFF Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update (GlobeNewswire)
May-01-24 05:07PM	TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering (GlobeNewswire) -7.49%
Apr-30-24 05:53AM	TFF Pharmaceuticals Prices $4.8 Million Public Offering; Shares Down Pre-Bell (MT Newswires)
Apr-29-24 08:00PM	TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering (GlobeNewswire) -7.24%
10:00AM	TFF Pharmaceuticals Makes Available Phase 2 Data from Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection Presented at the Recent ISHLT Annual Meeting (GlobeNewswire)
Apr-15-24 07:00AM	TFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessions (GlobeNewswire) -8.57%
Mar-28-24 10:54PM	TFFP Stock Earnings: TFF Pharmaceuticals Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace) -8.35% +6.13%
04:05PM	TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-27-24 04:01PM	TFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical Programs (GlobeNewswire)
Mar-25-24 09:01AM	TFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting (GlobeNewswire)
Mar-22-24 03:11PM	TFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) -6.33%
Mar-20-24 12:00PM	TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) -10.37%
09:03AM	TFF Pharmaceuticals Announces Update on Clinical Programs (GlobeNewswire)
04:47PM	Loading…
Mar-14-24 04:47PM	TFF Pharmaceuticals to Participate in the 36th Annual Roth Conference March 17-19, 2024 (GlobeNewswire)
Jan-24-24 08:00AM	TFF Pharmaceuticals to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Invasive Pulmonary Aspergillosis at the 11th Advances Against Aspergillosis & Mucormycosis Conference (GlobeNewswire) +10.88%
Jan-09-24 08:00AM	TFF Pharmaceuticals Announces Acceptance of Late-Breaking Abstract for Presentation at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting (GlobeNewswire)
Dec-20-23 10:52AM	TFFP Stock Earnings: TFF Pharmaceuticals Beats EPS, Misses Revenue for Q1 2023 (InvestorPlace) +6.84%
10:52AM	TFFP Stock Earnings: TFF Pharmaceuticals Beats EPS, Beats Revenue for Q2 2023 (InvestorPlace)
Dec-19-23 06:00AM	TFF Pharmaceuticals Announces Positive Initial Data from Ongoing Phase 2 Trials of TFF VORI and TFF TAC (GlobeNewswire) -8.63%
Dec-18-23 04:01PM	TFF Pharmaceuticals to Host Webcast and Conference to Review Initial Data from the Ongoing Phase 2 Trials of TFF VORI and TFF TAC (GlobeNewswire)
Dec-15-23 07:00AM	TFF Pharmaceuticals Announces Reverse Stock Split (GlobeNewswire) -14.28%
Dec-13-23 08:00AM	TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors (GlobeNewswire)
Nov-30-23 08:00AM	TFF Pharmaceuticals Appoints Michael Patane, Ph.D., to Board of Directors (GlobeNewswire) +15.48%
08:00AM	TFF Pharmaceuticals Appoints Catherine Lee, J.D. to Board of Directors (GlobeNewswire)
Nov-27-23 07:00AM	TFF Pharmaceuticals to Participate in the 2023 Benchmark Discovery One-on-One Investor Conference December 7, 2023 (GlobeNewswire)
Nov-16-23 08:37AM	TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-14-23 04:05PM	TFF Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire) +8.14%
Nov-08-23 04:05PM	TFF Pharmaceuticals Announces Publication of Data Demonstrating Feasibility of Intranasal Delivery of Monoclonal Antibodies with Thin Film Freezing (GlobeNewswire) -9.85%
Nov-07-23 04:05PM	TFF Pharmaceuticals to Hold Third Quarter 2023 Financial and Business Results Conference Call on November 14, 2023 (GlobeNewswire) -6.05%
Oct-02-23 05:00PM	TFF Pharmaceuticals Congratulates our Scientific Advisory Board Member, Drew Weissman, M.D., Ph.D., for Receiving the Nobel Prize in Physiology or Medicine for his Pioneering Work Enabling the Development of mRNA COVID-19 Vaccines (GlobeNewswire)
Sep-28-23 04:29PM	TFF Pharmaceuticals to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-23-23 07:00AM	TFF Pharmaceuticals to Participate in the H.C. Wainwright 25th Annual Global Investment Conference September 11-13, 2023 (GlobeNewswire) -5.33%
Aug-17-23 04:01PM	TFF Pharmaceuticals Announces Closing of $5.7 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option (GlobeNewswire)
06:36AM	TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-16-23 04:25AM	Q2 2023 TFF Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) -9.76%
Aug-15-23 06:05AM	TFF Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire) -8.89%
06:00AM	TFF Pharmaceuticals Prices $5 Million Public Offering of Common Stock (GlobeNewswire)
Aug-14-23 04:01PM	TFF Pharmaceuticals Announces Proposed Public Offering of Common Stock (GlobeNewswire) +8.43%
Aug-09-23 08:30AM	TFF Pharmaceuticals to Hold Second Quarter 2023 Financial and Business Results Conference Call on August 15, 2023 (GlobeNewswire)
Aug-08-23 05:50PM	Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
Jul-31-23 07:00AM	TFF Pharmaceuticals Inc. and Uniphar Durbin Ireland Ltd. Announce the Opening of an Expanded Access Program for Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Pulmonary Aspergillosis and Other Voriconazole Responsive Fungal Pulmonary Infections (GlobeNewswire) +11.37%
Jun-26-23 07:00AM	TFF Pharmaceuticals Awarded $2.97 Million to Develop Universal Influenza Vaccine (GlobeNewswire)
May-23-23 04:05PM	TFF Pharmaceuticals to Participate in the 2023 Jefferies Healthcare Conference (GlobeNewswire) -8.94%
May-11-23 04:05PM	TFF Pharmaceuticals Provides Corporate Update and Reports First Quarter 2023 Financial Results (GlobeNewswire) +5.97%
May-09-23 07:15AM	Sidoti's Micro-Cap Virtual May Conference (ACCESSWIRE)
May-04-23 08:00AM	TFF Pharmaceuticals Enters into CRADA with the National Institute of Environmental Health Sciences to Develop Dry Powder Formulations of Hyaluronan to Prevent and Treat Respiratory Diseases (GlobeNewswire) +15.64%
May-01-23 07:00AM	TFF Pharmaceuticals Receives Additional Funding from Leidos to Advance Next-Generation Personalized Protective Biosystems under the DARPA PPB Program (GlobeNewswire)
Apr-08-23 08:58AM	We're A Little Worried About TFF Pharmaceuticals' (NASDAQ:TFFP) Cash Burn Rate (Simply Wall St.)
Mar-07-23 04:15PM	TFF Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results (GlobeNewswire)
Mar-06-23 04:05PM	TFF Pharmaceuticals to Participate in the 35th Annual Roth Conference (GlobeNewswire)
Feb-23-23 01:01PM	3 Bargain Stocks Worth Buying at These 52-Week Lows (InvestorPlace) +17.36%
Feb-08-23 04:05PM	TFF Pharmaceuticals Appoints Harlan Weisman, M.D. as Permanent Chief Executive Officer (GlobeNewswire)
Jan-09-23 08:00AM	TFF Pharmaceuticals Announces the Appointment of Zamaneh Mikhak, M.D. as Chief Medical Officer (GlobeNewswire)
Dec-05-22 06:30AM	TFF Pharmaceuticals Announces Leadership Transition (GlobeNewswire)
Nov-29-22 04:01PM	TFF Pharmaceuticals Announces Closing of $12.3 Million Public Offering (GlobeNewswire)
Nov-21-22 01:40PM	15 Most Volatile Stocks to Buy Now (Insider Monkey) +5.98%
Nov-18-22 08:00AM	TFF Pharmaceuticals Prices $10.675 Million Offering of Common Stock and Warrants (GlobeNewswire) -9.30%
Nov-17-22 04:01PM	TFF Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants (GlobeNewswire)
05:34AM	TFF Pharmaceuticals Third Quarter 2022 Earnings: US$0.29 loss per share (vs US$0.34 loss in 3Q 2021) (Simply Wall St.)
Nov-14-22 04:01PM	TFF Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire) -12.43% -18.92%
Nov-07-22 04:05PM	TFF Pharmaceuticals to Hold Third Quarter 2022 Financial and Business Results Conference Call on November 14, 2022 (GlobeNewswire) -11.67%
Nov-03-22 08:00AM	TFF Pharmaceuticals Announces Collaboration with Aptar Pharma to Explore and Develop Intranasal Delivery of Dry Powder Vaccines and Dry Powder Therapeutics (GlobeNewswire) +14.94%
Nov-02-22 12:47PM	Why TFF Pharmaceuticals Shares Are Sinking Today? (Benzinga) -35.56%
Nov-01-22 04:07PM	TFF Pharmaceuticals Announces Second Patient Successfully Treated with Voriconazole Inhalation Powder Through Compassionate Use Program (GlobeNewswire) +8.00%
04:05PM	TFF Pharmaceuticals Announces Program Updates for Voriconazole Inhaled Powder and Tacrolimus Inhaled Powder Clinical Programs (GlobeNewswire)
Oct-18-22 10:23AM	Is TFF Pharmaceuticals (NASDAQ:TFFP) In A Good Position To Deliver On Growth Plans? (Simply Wall St.)
Oct-11-22 08:00AM	TFF Pharmaceuticals Announces Presentation of Data Featuring Applications of Thin Film Freezing Technology at AAPS PharmSci 360 Meeting (GlobeNewswire)
Sep-26-22 08:00AM	TFF Pharmaceuticals to Participate in the Roth Inaugural Healthcare Opportunities Conference (GlobeNewswire) -5.15%
Sep-22-22 08:00AM	TFF Pharmaceuticals Announces Acceptance of Multiple Abstracts Featuring Applications of Thin Film Freezing Technology at the Upcoming AAPS PharmSci 360 Meeting (GlobeNewswire)
Sep-08-22 08:00AM	TFF Pharmaceuticals Announces Presentation of Patient Data with Voriconazole Inhalation Powder (TFF VORI) at the 15th International Congress on Lung Transplantation (GlobeNewswire) +13.60%
Sep-06-22 08:00AM	TFF Pharmaceuticals to Participate at The H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Aug-12-22 11:30AM	TFF Pharmaceuticals, Inc. (TFFP) Q2 2022 Earnings Call Transcript (Motley Fool)
Aug-11-22 04:05PM	TFF Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Aug-02-22 04:05PM	TFF Pharmaceuticals to Hold Second Quarter 2022 Financial and Business Results Conference Call on August 11, 2022 (GlobeNewswire) +6.09%
Jul-14-22 08:00AM	TFF Pharmaceuticals Expands R&D Operations with New Austin Facility (GlobeNewswire)
Jun-24-22 03:44PM	TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Is Expected To Breakeven In The Near Future (Simply Wall St.)
Jun-09-22 08:00AM	TFF Pharmaceuticals to Participate at The JMP Securities Life Sciences Conference (GlobeNewswire)
Jun-01-22 08:00AM	TFF Pharmaceuticals to Participate at the Jefferies Healthcare Conference (GlobeNewswire)
May-31-22 09:55AM	Wall Street Analysts Think TFF Pharmaceuticals, Inc. (TFFP) Could Surge 233%: Read This Before Placing a Bet (Zacks) -7.24%
May-20-22 09:32AM	TFF Pharmaceuticals to Participate at the H.C. Wainwright Global Investment Conference (GlobeNewswire)
May-11-22 05:15PM	TFF Pharmaceuticals, Inc. (TFFP) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -5.00%
04:01PM	TFF Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
May-10-22 03:34PM	Is TFF Pharmaceuticals (NASDAQ:TFFP) In A Good Position To Invest In Growth? (Simply Wall St.)

TFF Pharmaceuticals, Inc. engages in the development and commercialization of drug products based on its patented Thin Film Freezing technology platform. It focuses on the manufacture of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company was founded on January 24, 2018 and is headquartered in Fort Worth, TX.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TFFP

Tff Pharmaceuticals Inc

Upgrade your FINVIZ experience